GlassScriptPhysician profile
Matthew Spivey
NPI 1619331873
$19,115.08
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $1,135 · 2021: $1,205 · 2022: $7,150 · 2023: $9,378 · 2024: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,760 · Education: $2,500 · Food and Beverage: $2,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,759.51 |
| Education | $2,500.00 |
| Food and Beverage | $2,249.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,409.63 | 2022-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Fortis Surgical, LLC | $3,804.48 | 2020-2023 | |
| Stryker Corporation | $2,796.61 | 2022-2023 | Salvation, Nanopass, Na |
| Arthrex, INC. | $2,234.94 | 2023 | Arthrex |
| Exactech, INC. | $1,593.75 | 2022 | |
| Tricoast Surgical Solutions LLC | $1,434.39 | 2022-2024 | |
| Piedmont Plus Innovation | $825.22 | 2023 | |
| Medical Device Business Services, INC. | $668.86 | 2023 | Dynacord |
| Globus Medical, INC. | $158.07 | 2022 | |
| Vericel Corporation | $115.38 | 2019 | |
| Depuy Synthes Sales INC. | $73.75 | 2023 | Dynacord |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Spivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.